Scientists identify gene for resistance to parasitic 'witchweed'
The parasitic flowering plant Striga, or "witchweed," attacks the roots of host plants, draining needed water and nutrients and leaving them unable to grow and produce any grains. Witchweed is endemic throughout sub-Saharan Africa, causing crop losses that surpass hundreds of millions of dollars annually and exacerbating food shortages in the region. Among the crops heavily parasitized by witchweed is black-eyed pea, known in Africa as "cowpea" or "niebe" in Francophone countries.
As the use of cowpea expanded over time, so did the prevalence of Striga gesnerioides, the type of witchweed adapted to parasitize it. Today, witchweed is so virulent that farmers must relocate their cowpea crop to new soil every few years.
Now, scientists at the University of Virginia have identified a gene in cowpea that confers resistance to witchweed attack. This discovery will help researchers better understand how some plants can resist Striga, while others, such as corn and sorghum, are susceptible. The findings are presented in Science .
"Discovery of this resistance gene is not only important for improving cowpea, but may help us develop strategies for improving resistance to Striga in other affected crops," said Michael P.Timko, the U.Va. biology professor who led the study.
Currently there are no natural sources of Striga resistance in corn or sorghum, both of which are major cereal grains in the African diet.
"It is now possible for us to identify all possible genes for Striga resistance in cowpeas, as well as resistance to other cowpea pathogens," Timko said. "We may even eventually breed a more drought-resistant plant and varieties that have higher levels and a better balance of nutrients. We've reached a point where we can manipulate this plant for the good of millions of people."
Other news from the department science

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
Last viewed contents
AEterna Zentaris Announces Completion of Patient Enrollment for Ozarelix Phase II Trial in Benign Prostatic Hyperplasia
Reverse negative impact of ultraviolet radiation on skin
Algeta completes enrolment of 900 patients into phase III ALSYMPCA trial with Alpharadin - Primary endpoint is overall survival in castration-resistant prostate cancer (CRPC) patients with bone metastases
